Publication | Open Access
Effects of Semelil (ANGIPARS™) on diabetic peripheral neuropathy: A randomized, double-blind Placebo-controlled clinical trial.
10
Citations
1
References
2011
Year
The results showed limited evidence of efficacy of ANGIPARS™ in diabetic neuropathy treatment and more studies with a larger sample size and longer duration are required.
| Year | Citations | |
|---|---|---|
Page 1
Page 1